Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1217
| Despition | P2Y2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1497 | Human AMIGO2 Protein (AC1497) | 2 µg | inquiry |
| ACPP-1274 | Visfatin Blocking Peptide (AC1274) | 250 µg | inquiry |
| ACPP-1620 | Human SIX6 Protein (AC1620) | 5 µg | inquiry |
| ACPP-1484 | Human CPE Protein (AC1484) | 5 µg | inquiry |
| ACPP-1722 | Human SRR Protein (AC1722) | 1 µg | inquiry |
| ACPP-1644 | Human Vimentin Protein (AC1644) | 20 µg | inquiry |
| ACPP-1415 | Human GNAQ Protein (AC1415) | 5 µg | inquiry |
| ACPP-1660 | Mouse GDF7 Protein (AC1660) | 2 µg | inquiry |
| ACPP-1044 | Recombinant Human RAGE Protein (6×His Tag) (AC1044) | 50 µg | inquiry |
| ACPP-1557 | Human TARDBP Protein (AC1557) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.